The expression of the OPN proteins was mainly regulated by the WDR5–H3K4me3 epigenetic axis, and the inhibition of WDR5 significantly improved the effect of anti-PD-1 immunotherapy in inhibiting pancreatic cancer growth in vivo. Here, SPP1 is linked to pancreatic neoplasm.